OLD Category: Oncology

Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma

• Openshaw MR, Mohamed AA, Ottolini B, Fernandez-Garcia D, Richards CJ, Page K, Guttery DS, Thomas AL, Shaw JA

Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma

• Yao Y, Yan Z, Lian S, Wei L, Zhou C, Feng D, Zhang Y, Yang J, Li M, Chen Y

Circulating miR-16-5p, miR-92a-3p, and miR-451a in Plasma from Lung Cancer Patients: Potential Application in Early Detection and a Regulatory Role in Tumorigenesis Pathways

• Reis PP, Drigo SA, Carvalho RF, Lopez Lapa RM, Felix TF, Patel D, Cheng D, Pintilie M, Liu G, Tsao MS

PTEN Function at the Interface between Cancer and Tumor Microenvironment: Implications for Response to Immunotherapy

• Conciatori F, Bazzichetto C, Falcone I, Ciuffreda L, Ferretti G, Vari S, Ferraresi V, Cognetti F, Milella M

Next Generation Sequencing for Gene Fusion Analysis in Lung Cancer: A Literature Review

• Bruno R, Fontanini G

Using Reverse Phase Protein Arrays (RPPA) to identify and target adaptive resistance

• Labrie M, Fang Y, Kandsersky N, Li J, Liang H, Westin SN, Mitri Z, Mills GB

Expression levels of circulating miRNAs as biomarkers during multimodal treatment of rectal cancer – TiMiSNAR-mirna: a substudy of the TiMiSNAR Trial (NCT03962088)

• Monsellato I, Garibaldi E, Cassinotti E...Fusco V, Torri V, Orecchia S

miRNA profiling of biliary intraepithelial neoplasia reveals stepwise tumorigenesis in distal cholangiocarcinoma via the miR-451a/ATF2 axis

• Loeffler MA, Hu J, Kirchner M...Ji J, Roessler S, Goeppert B

MAM domain containing 2 is a potential breast cancer biomarker that exhibits tumour‐suppressive activity

• Lee H, Park B, Soon Kang J, Cheon Y, Lee S, Jae Maeng P

Frequent Molecular Subtype Switching and Gene Expression Alterations in Lung and Pleural Metastasis From Luminal A-Type Breast Cancer

• Klebe M, Fremd C, Kriegsmann M...Schneeweiss A, Winter H, Sinn P

Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade

• Peranzoni E, Ingangi V, Masetto E, Pinton L, Marigo I

Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer

• Martini G, Dienstmann R, Ros J...Argiles G, Tabernero J, Elez E